EXHIBIT 4e

                    AGREEMENT FOR NONQUALIFIED STOCK OPTIONS
                              FOR CLINICAL ADVISOR

     THIS OPTION AGREEMENT (the  "Agreement") is made and entered into effective
as of the __ day of ____, _____, by and between Atrion  Corporation,  a Delaware
corporation  (the  "Company"),  and  ____________________________,   a  Clinical
Advisor (the "Participant").

                              W I T N E S S E T H :
                              - - - - - - - - - -

     WHEREAS,  the  Participant is currently  serving as a Clinical  Advisor for
Quest Medical, Inc. ("Quest"), a wholly-owned subsidiary of the Company; and

     WHEREAS,  the Company desires to encourage the Participant to own shares of
common  stock of the Company  ("Shares")  and to give the  Participant  an added
incentive to advance the interests of the Company.

     NOW,  THEREFORE,  for and in  consideration  of the  premises,  the  mutual
promises  and  covenants   herein   contained,   and  other  good  and  valuable
consideration,  the  receipt,  adequacy  and  sufficiency  of which  are  hereby
acknowledged, the parties hereto do hereby agree as follows:

     1. Subject to the execution of this  Agreement,  the Company has granted to
the  Participant  an option (the  "Option")  to purchase  from the Company  such
number of whole  Shares as is set forth on  Exhibit A attached  hereto  from the
authorized and unissued common stock of the Company,  or from the treasury stock
of the Company, at and for the price set forth on Exhibit A attached hereto (the
"Option Price"). The Option has been designated as a nonqualified stock option.

     2.  The  Option  shall be  exercised  by  delivery  to the  Company  at its
principal office of written notice of the  Participant's  intent to exercise the
Option with respect to the number of Shares then being purchased, accompanied by
payment in full to the Company of the amount of the Option  Price for the number
of Shares then being  purchased.  The Option  Price upon  exercise of the Option
shall be payable to the Company (a) in cash or its equivalent,  (b) by tendering
previously  acquired  Shares  having an aggregate  Fair Market Value (as defined
below) at the time of exercise  equal to the aggregate  Option Price or (c) by a
combination  of (a) and (b).  The Option  Price  shall be paid  directly  by the
Participant;  however,  if the  exercise  of the  Option is in  accordance  with
Section  220.3(e) of Regulation T  promulgated  by the Board of Governors of the
Federal  Reserve  System (a "cashless  exercise"),  the Option Price may be paid
directly by a registered  broker-dealer for the account of the Participant.  The
term "Fair Market  Value"  means,  as of any date,  the closing sales price of a
Share on such date as reported by (a) any national  securities exchange on which
the Shares are  actively  traded or (b) The Nasdaq Stock Market or, if no Shares
are traded on such exchange or system on such date,  then on the next  preceding
date on which any Shares were traded on such exchange or system.

     3.  The  Option  may  be  exercised  and  Shares  may be  purchased  by the
Participant  as the result of such  exercise  only  during the term set forth on
Exhibit A attached hereto;  provided,  however, that in no event shall the total
number of Shares  purchased  hereunder  pursuant  to the


                                       9
<PAGE>

exercise of the Option exceed the number set forth on Exhibit A attached hereto,
as the same may be adjusted in  accordance  with  Paragraph 8 hereof,  and in no
event shall the period for  exercising the Option exceed ten (10) years from the
date of the  grant of the  Option.  Exercise  of the  Option is  subject  to the
following additional terms and conditions:

               (a) In the event the Participant  ceases to be a Clinical Advisor
          other than as a result of the  Participant's  death, the Option may be
          exercised at any time after the date of such  cessation and before the
          earlier of (i) three (3) months  and (ii) the  expiration  date of the
          Option.

               (b) In the event the Participant  ceases to be a Clinical Advisor
          by reason of the  Participant's  death, the Option may be exercised at
          any time after the date of Participant's  death and before the earlier
          of (i) six (6) months after the date of  Participant's  death and (ii)
          the expiration date of the Option.

     4. In case of any exercise of the Option,  this  Agreement,  accompanied by
payment of the full  purchase  price for the  Shares  then  being  purchased  as
provided in Paragraph 2 above, shall be surrendered to the Company.  The Company
will thereupon cause to be issued and delivered to the  participant  (or, in the
event of a cashless exercise,  to the Participant's  broker-dealer),  as soon as
reasonably practicable, a certificate or certificates representing the Shares so
purchased  and fully paid for. In the event of a partial  exercise,  the Company
will  endorse  on  Exhibit B  attached  hereto the fact that the Option has been
partially exercised on such date, setting forth the extent of such exercise, and
return this Agreement to the Participant.

     5. The Option is personal to the  Participant  and may not in any manner or
respect be assigned or transferred otherwise than by will or the laws of descent
and distribution,  and is exercisable during the participant's  lifetime only by
the Participant.  To the extent the Option is not exercised,  the Shares covered
hereby shall be considered released to the Company.

     6. The  Option is in all  respects  subject  to and shall be  governed  and
determined  by any rules which might be adopted by the Board of Directors of the
Company with  respect  thereto to the same extent and with the same effect as if
set forth fully herein.

     7. This  Agreement  shall  terminate  no later than ten (10) years from the
date of grant of the Option.

     8. In the event of any change in corporate capitalization,  such as a stock
dividend  or  stock  split,  or a  corporate  transaction,  such as any  merger,
consolidation,  separation, including a spin-off, or other distribution of stock
or  property  of  the  Company,   any   reorganization   (whether  or  not  such
reorganization  comes within the  definition  of such term in Section 368 of the
Internal  Revenue Code) or any partial or complete  liquidation  of the Company,
such adjustment  shall be made in the number,  class and price of Shares subject
to the Option as may be determined to be appropriate  and equitable by the Board
of Directors  of the Company,  in its sole  discretion,  to prevent  dilution or
enlargement of rights;  provided,  however, that the number of Shares subject to
the Option shall always be a whole number.


                                       10
<PAGE>

     9. This Agreement shall be governed by and construed in accordance with the
laws  of  the  State  of  Delaware,   applied   without  giving  effect  to  any
conflict-of-law principles. Any invalidity or unenforceability of any particular
provision of this Agreement shall not affect the other  provisions  hereof,  and
this  Agreement  shall  be  construed  in all  respects  as if such  invalid  or
unenforceable provisions were omitted.

     10. This Agreement  shall be binding upon and shall inure to the benefit of
each of the  parties  hereto  and their  respective  executors,  administrators,
personal  representatives,   legal  representatives,  heirs  and  successors  in
interest.

     11. This Agreement may be executed in any number of  counterparts,  each of
which shall be  considered an original,  and such  counterparts  shall  together
constitute and be one and the same instrument.

     12. Upon demand by the Company,  the  Participant  agrees to deliver to the
Company at the time of any complete or partial exercise of this Option a written
representation  that the Shares  being  acquired  upon such  exercise  are being
acquired for  investment  and not for resale or with a view to the  distribution
thereof.

     13. The Company  shall have the power and the right to deduct or  withhold,
or require the  Participant  to remit to the Company,  an amount  sufficient  to
satisfy  federal,  state and  local  taxes  (including  the  Participant's  FICA
obligation)  required by law to be withheld  with  respect to any taxable  event
arising as a result of the grant or  exercise  of the  Option.  With  respect to
withholding required upon the exercise of the Option, the Participant may elect,
subject to the approval of the Board of Directors of the Company, to satisfy the
withholding  requirement,  in whole or in part,  by having the Company  withhold
Shares  having a Fair  Market  value  on the  date as of which  the tax is to be
determined  equal to the minimum  statutory  total tax which could be imposed on
the  transaction.  All such  elections  shall be  irrevocable,  made in writing,
signed by the  Participant,  and subject to any restrictions or limitations that
the  Board  of  Directors  of  the  Company,  in  its  sole  discretion,   deems
appropriate.

     IN WITNESS  WHEREOF,  the Company and the  Participant  have  executed  and
delivered this Agreement as of the day and year first written above.

                                            ATRION CORPORATION


                                            By:
                                                  ------------------------------
                                            Name:
                                                  ------------------------------
                                            Title:
                                                  ------------------------------

                                            PARTICIPANT


                                            Name:
                                                  ------------------------------

                                       11

<PAGE>


                                    EXHIBIT A

                                       TO

                                OPTION AGREEMENT


         Participant:                              ___________________________

         Grant Date:                               ___________________________

         Option Price:                             $12.25





                                      Can Only Be                 Must Be
Shares Subject to Option            Exercised After           Exercised Before
------------------------            ---------------           ----------------












                                       12

<PAGE>


                                    EXHIBIT B

                                       TO

                                OPTION AGREEMENT



         Pursuant to Paragraph 4 hereof, record partial exercise below:


                                PARTIAL EXERCISE




                        Signature of
No. of Shares              Date of             No. of Share          Endorsing
    Exercised             Exercise              Remaining             Officer
----------------          --------             ------------          ----------



                                       13